Clinical Utility of Rilonacept for the Treatment of Recurrent Pericarditis: Design, Development, and Place in Therapy
Drug Design, Development and Therapy · 2024-09 · Volume 18 · 3939-3950
DOI: 10.2147/dddt.s261119 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2024-09. Verfasst von Panayotis K Vlachakis und 5 weiteren Autor:innen. Beteiligte Einrichtung: First Cardiology Department, School of Medicine, Hippokration General Hospital, National and Kapodistrian University of Athens, Athens, 11527, Greece. Hauptthemen laut MEDLINE: Pericarditis, Recombinant Fusion Proteins, Recurrence. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- First Cardiology Department, School of Medicine, Hippokration General Hospital, National and Kapodistrian University of Athens, Athens, 11527, Greece.
ORCID-Profile: Panagiotis Theofilis, Konstantinos Tsioufis, George Lazaros
Zitieren
APA
Vlachakis, P. K., Theofilis, P., Soulaidopoulos, S., Lazarou, E., Tsioufis, K., & Lazaros, G. (2024). Clinical Utility of Rilonacept for the Treatment of Recurrent Pericarditis: Design, Development, and Place in Therapy. Drug Design, Development and Therapy, Volume 18, 3939-3950. https://doi.org/10.2147/dddt.s261119
Vancouver
Vlachakis PK, Theofilis P, Soulaidopoulos S, Lazarou E, Tsioufis K, Lazaros G. Clinical Utility of Rilonacept for the Treatment of Recurrent Pericarditis: Design, Development, and Place in Therapy. Drug Design, Development and Therapy. 2024;Volume 18:3939-3950. doi:10.2147/dddt.s261119
BibTeX
@article{Vlachakis2024,
author = {Vlachakis, Panayotis K and Theofilis, Panagiotis and Soulaidopoulos, Stergios and Lazarou, Emilia and Tsioufis, Konstantinos and Lazaros, George},
title = {Clinical Utility of Rilonacept for the Treatment of Recurrent Pericarditis: Design, Development, and Place in Therapy},
journal = {Drug Design, Development and Therapy},
year = {2024},
volume = {Volume 18},
pages = {3939--3950},
doi = {10.2147/dddt.s261119}
}
EUVIMED